Get the Stockscreener App
9.34
1.08%
0.10
After Hours:
9.34
Newamsterdam Pharma Company N V Stock (NAMSW) Forecast
The Newamsterdam Pharma Company N V (NAMSW) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.7266, representing a -17.27% decrease from the current price of $9.34. The highest analyst price target is $9.3409, and the lowest is $6.1123.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NAMSW Price Target
Average 5.7329
(-38.62% Downside)
Is Newamsterdam Pharma Company N V (NAMSW) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.60 | Neutral |
| STOCH(9,6) | 82.11 | Sell |
| STOCHRSI(14) | 95.84 | Sell |
| MACD(12,26) | -0.0868 | Buy |
| ADX(14) | 23.50 | Neutral |
| William %R | -5.00 | Sell |
| CCI(14) | 71.92 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.653
Buy
|
8.7671
Buy
|
| MA20 |
7.867
Buy
|
8.6748
Buy
|
| MA50 |
9.2369
Buy
|
9.3066
Buy
|
| MA100 |
10.69
Sell
|
9.7076
Sell
|
| MA200 |
9.5338
Sell
|
9.5696
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, NAMSW could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on NAMSW, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 54.6 indicates that NAMSW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 82.11 indicates that NAMSW is oversold. This means that NAMSW price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 95.84 indicates that NAMSW is oversold. This suggests that NAMSW price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.5 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 71.92 indicates that NAMSW is still overbought but not to an extreme extent.
Long-term NAMSW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Newamsterdam Pharma Company N V financial reports and earnings history, Newamsterdam Pharma Company N V (NAMSW) stock could reach $13.05 by 2030, $87.03 by 2040 and $173.84 by 2050. See the projected annual prices until 2050 of the Newamsterdam Pharma Company N V stock below:
- Newamsterdam Pharma Company N V (NAMSW) is expected to reach an average price of $34.29 in 2035, with a high prediction of $41.15 and a low estimate of $35.29. This indicates an $267.09% rise from the last recorded price of $9.34.
- Newamsterdam Pharma Company N V (NAMSW) stock is projected to chart a bullish course in 2040, with an average price target of $69.41, representing an $643.19% surge from its current level. The forecast ranges from a conservative $72.28 to a sky-high $87.03.
- Our analysts predict Newamsterdam Pharma Company N V (NAMSW) to jump 1,151% by 2045, soaring from $120.15 to an average price of $116.89, potentially reaching $139.64. While $120.15 is the low estimate, the potential upside is significant.
- Newamsterdam Pharma Company N V (NAMSW) stock is expected to climb by 2050, reaching an average of $173.85, a $1,761% jump from its current level. However, a wide range of estimates exists, with high and low targets of $173.84 and $6.5545, respectively, highlighting the market's uncertainty.
Newamsterdam Pharma Company N V Stock (NAMSW) Year by Year Forecast
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2025
Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $5.7025 in 2025, with a high prediction of $11.14 and a low estimate of $0.2618. This indicates an -38.95% fall from the last recorded price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $7.9795 | $6.1123 | $9.3409 | -14.57% |
| July, 2025 | $8.9528 | $7.4955 | $10.75 | -4.15% |
| August, 2025 | $6.9951 | $7.3536 | $8.5363 | -25.11% |
| September, 2025 | $1.0591 | $0.8091 | $5.8609 | -88.66% |
| October, 2025 | $5.09 | $1.2455 | $8.54 | -45.50% |
| November, 2025 | $7.0727 | $4.9464 | $8.3045 | -24.27% |
| December, 2025 | $7.8455 | $6.9773 | $10.37 | -16.00% |
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2026
The predicted value for Newamsterdam Pharma Company N V (NAMSW) in 2026 is set at an average of $8.5829. Estimates vary from a peak of $17.09 to a trough of $0.0795, indicating an -8.11% surge from the present price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.586 | $8.2136 | $11.39 | +2.63% |
| February, 2026 | $1.0136 | $3.0114 | $5.8068 | -89.15% |
| March, 2026 | $3.8773 | $0.0795 | $4.2273 | -58.49% |
| April, 2026 | $6.1659 | $0.4597 | $7.2682 | -33.98% |
| May, 2026 | $7.4568 | $6.4591 | $9.9773 | -20.16% |
| June, 2026 | $13.19 | $7.9545 | $14.24 | +41.25% |
| July, 2026 | $3.0864 | $5.2136 | $12.18 | -66.96% |
| August, 2026 | $2.3227 | $0.1727 | $2.6727 | -75.13% |
| September, 2026 | $4.2918 | $0.9653 | $6.2318 | -54.05% |
| October, 2026 | $7.0682 | $4.8891 | $9.5887 | -24.32% |
| November, 2026 | $15.91 | $7.6955 | $17.09 | +70.38% |
| December, 2026 | $5.1591 | $7.4159 | $14.77 | -44.76% |
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Newamsterdam Pharma Company N V (NAMSW) is $11.53, with a high forecast of $22.79 and a low forecast of $0.2827. This indicates an +23.50% increase from the last price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7682 | $1.3818 | $4.2323 | -91.78% |
| February, 2027 | $3.2555 | $1.4486 | $5.1955 | -65.15% |
| March, 2027 | $6.8327 | $3.9823 | $6.8327 | -26.84% |
| April, 2027 | $18.63 | $6.2795 | $19.94 | +99.50% |
| May, 2027 | $5.1182 | $9.6182 | $17.36 | -45.20% |
| June, 2027 | $3.9727 | $4.9727 | $6.1755 | -57.47% |
| July, 2027 | $2.2191 | $0.2827 | $4.1591 | -76.24% |
| August, 2027 | $6.3145 | $3.0755 | $6.3145 | -32.39% |
| September, 2027 | $21.35 | $5.8909 | $22.79 | +128.63% |
| October, 2027 | $7.3205 | $11.82 | $19.95 | -21.62% |
| November, 2027 | $5.6568 | $6.6568 | $8.1186 | -39.43% |
| December, 2027 | $1.1827 | $0.3409 | $3.1227 | -87.34% |
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2028
In 2028, Newamsterdam Pharma Company N V (NAMSW) is projected to reach an average price of $15.85, with a high projection of $31.34 and a low estimate of $0.355. This indicates an +69.65% rise from the last price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.7964 | $2.1686 | $5.7964 | -37.94% |
| February, 2028 | $25.65 | $5.5023 | $25.64 | +174.63% |
| March, 2028 | $9.5227 | $14.02 | $24.07 | +1.96% |
| April, 2028 | $7.3409 | $8.3409 | $10.06 | -21.40% |
| May, 2028 | $2.0491 | $0.9545 | $3.5455 | -78.06% |
| June, 2028 | $5.2782 | $0.3836 | $5.2782 | -43.49% |
| July, 2028 | $28.50 | $5.1136 | $28.49 | +205.14% |
| August, 2028 | $11.72 | $16.22 | $26.80 | +25.54% |
| September, 2028 | $9.025 | $10.02 | $12.01 | -3.37% |
| October, 2028 | $3.215 | $2.25 | $5.10 | -65.58% |
| November, 2028 | $4.76 | $0.355 | $4.76 | -49.04% |
| December, 2028 | $31.35 | $4.725 | $31.34 | +235.65% |
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2029
The 2029 price forecast for Newamsterdam Pharma Company N V Stock (NAMSW) is $18.76 on average, with a high prediction of $37.04 and a low estimate of $0.4755. This represents an +100.81% increase from the previous price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.20 | $24.04 | $29.52 | +116.29% |
| February, 2029 | $12.90 | $13.26 | $13.95 | +38.15% |
| March, 2029 | $4.3809 | $3.5455 | $9.6791 | -53.10% |
| April, 2029 | $2.7873 | $0.5518 | $3.0873 | -70.16% |
| May, 2029 | $34.20 | $2.8318 | $34.19 | +266.17% |
| June, 2029 | $22.53 | $26.37 | $32.24 | +141.26% |
| July, 2029 | $14.72 | $15.08 | $15.89 | +57.57% |
| August, 2029 | $5.5468 | $4.8409 | $11.36 | -40.61% |
| September, 2029 | $2.1395 | $0.4755 | $2.4395 | -77.09% |
| October, 2029 | $5.2227 | $2.3136 | $8.1318 | -44.08% |
| November, 2029 | $24.87 | $28.70 | $37.04 | +166.23% |
| December, 2029 | $16.53 | $16.89 | $17.83 | +76.99% |
Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2030
Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $21.52 in 2030, with a high forecast of $42.74 and a low forecast of $0.3018. This signifies an +130.40% surge from the last price of $9.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.7127 | $6.1364 | $13.05 | -28.13% |
| February, 2030 | $1.4918 | $0.3018 | $2.0591 | -84.03% |
| March, 2030 | $4.8341 | $1.7955 | $7.8727 | -48.24% |
| April, 2030 | $30.74 | $34.01 | $39.89 | +229.13% |
| May, 2030 | $18.34 | $18.70 | $26.48 | +96.41% |
| June, 2030 | $7.2818 | $7.4318 | $14.73 | -22.04% |
| July, 2030 | $0.6191 | $1.0791 | $5.3186 | -93.37% |
| August, 2030 | $3.9739 | $0.3341 | $7.6136 | -57.45% |
| September, 2030 | $33.20 | $36.47 | $42.74 | +255.48% |
| October, 2030 | $20.16 | $20.52 | $28.81 | +115.83% |
| November, 2030 | $8.5773 | $8.7273 | $16.42 | -8.17% |
| December, 2030 | $1.3964 | $1.8564 | $6.4845 | -85.05% |
0.39%
3.66%
Cap:
|
Volume (24h):